Brian Cox is never one to mince his words when it comes to fellow Hollywood talents, having targeted his “25th Hour” co-star Edward Norton (“a pain in the arse”), Ian McKellen (“not to my taste”) and ...

The study, “Integration of phospho-signaling and transcriptomics in single cells reveals distinct Th17 cell fates,” was published in Cell Reports. In the study, first author Seth Fortmann, M.D., Ph.D.

Charli xcx reflected on playing a heightened version of herself in “Brat” mockumentary “The Moment” at its Berlin Film Festival press conference, joking that she went “Method from the day I was born” ...

If you are glued to the Olympic coverage as I am, you are seeing the commercial from Eli Lilly and Company. Lilly's advertisement uses the scientific method as a narrative frame, drawing a parallel ...

Michael Carrick is gaining support to become Manchester United’s next permanent manager, and his latest move has only added fuel to that conversation. Carrick has shown a knack for getting results ...

Seedance 2.0 officially launched on Thursday AI model wins praise on Weibo for generating complex videos Elon Musk comments boost buzz around Seedance 2.0 BEIJING, Feb 12 (Reuters) - ByteDance's new ...

Forbes contributors publish independent expert analyses and insights. Paul Hsieh, M.D., covers healthcare economics, innovation, and policy. It is too easy to focus on bad news and stressful events, ...

Chinese researchers have developed a novel method to efficiently engineer natural killer (NK) cells for cancer immunotherapy. NK cells are central to early antiviral and anticancer defense—among other ...

The precise imaging of many-body systems, which are comprised of many interacting particles, can help to validate theoretical models and better understand how individual particles in these systems ...

Discover how to confidently specify commercial roller shades that deliver both style and performance. This webinar introduces the S.H.A.D.E method - a step-by-step framework for smarter shade ...

HOUSTON, July 28, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development ...